Clovis Oncology, Inc. - stock earnings
Stock symbol CLVS is outdated, potentially delisted? Maybe it is available on other exchange?
CLVS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -56.0 million USD | 30.7 million USD |
| 2022Q2 | -71.3 million USD | 32.1 million USD |
| 2022Q1 | -60.2 million USD | 34.2 million USD |
| 2021Q4 | -64.4 million USD | 36.0 million USD |
| 2021Q3 | -67.4 million USD | 37.9 million USD |
| 2021Q2 | -66.4 million USD | 36.8 million USD |
| 2021Q1 | -66.3 million USD | 38.1 million USD |
| 2020Q4 | -99.0 million USD | 43.3 million USD |
| 2020Q3 | -78.7 million USD | 38.8 million USD |
CLVS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -264.5 million USD | 148.8 million USD |
| 2020 | -369.2 million USD | 164.5 million USD |
| 2019 | -400.4 million USD | 143.0 million USD |
| 2018 | -368.0 million USD | 95.4 million USD |
| 2017 | -346.4 million USD | 55.5 million USD |
CLVS
Price: $0.08
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.78 USD
P/E Ratio: -1.42
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -58.7 millionMarket Capitalization: 34.8 million